Tag Archive | "ipo"

Adaptimmune closes its initial public offering of $175.7 million

Tags: ,


Adaptimmune announced the closing of its initial public offering of 11,250,000 American Depositary Shares at a price to the public of $17.00 per ADS. Read the full story

Spark Therapeutics files for $86 million IPO

Tags: ,


Spark Therapeutics has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission Read the full story

Carbylan Therapeutics seeks $86 million IPO

Tags: ,


Carbylan Therapeutics, which is developing a novel, injectable treatment for osteoarthritis pain, filed with the SEC to raise up to $86 million Read the full story

Tracon Pharmaceuticals launches $58 million IPO bid

Tags: ,


TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, filed with the SEC to raise up to $58 million Read the full story

Asante Solutions proposes $45 million in IPO financing

Tags: ,


Asante Solutions has filed to raise up to $45 million in an IPO financing to help it further commercialize its insulin pump, which is designed to be easy to use and is cheaper than products by major competitors. Read the full story

Juno Therapeutics lands bumper $265 million IPO

Tags: ,


Juno Therapeutics announced the pricing of its initial public offering of 11,022,917 shares of common stock at a price to the public of $24.00 per share Read the full story

Medovex seeks $80 million IPO

Tags: ,


Medovex has priced its initial public offering of 1,391,305 units, each unit consisting of one share of common stock and one Series A Warrant, at a price to the public of $5.75 per unit Read the full story

Ascendis files for $86 million IPO

Tags: ,


Ascendis Pharma will go public, raising up to $86 million towards an IPO Read the full story

Midatech gains £32 million in AIM float

Tags: ,


Midatech announced the Admission to trading on the AIM Market of the London Stock Exchange of its entire issued share capital Read the full story

Second Sight secures $32 million IPO

Tags: , ,


Second Sight Medical Products secured it pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share Read the full story